1. Home
  2. IDCC vs BLCO Comparison

IDCC vs BLCO Comparison

Compare IDCC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InterDigital Inc.

IDCC

InterDigital Inc.

HOLD

Current Price

$337.94

Market Cap

6.6B

Sector

Miscellaneous

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$18.04

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDCC
BLCO
Founded
1972
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Multi-Sector Companies
Ophthalmic Goods
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.1B
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
IDCC
BLCO
Price
$337.94
$18.04
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$412.50
$18.45
AVG Volume (30 Days)
165.9K
356.1K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
N/A
EPS
5.51
N/A
Revenue
$307,404,000.00
$5,101,000,000.00
Revenue This Year
N/A
$8.65
Revenue Next Year
$3.38
$5.59
P/E Ratio
$60.94
N/A
Revenue Growth
N/A
6.47
52 Week Low
$249.14
$13.77
52 Week High
$412.60
$18.92

Technical Indicators

Market Signals
Indicator
IDCC
BLCO
Relative Strength Index (RSI) 56.08 71.26
Support Level $330.55 $16.26
Resistance Level $336.25 $18.92
Average True Range (ATR) 10.68 0.42
MACD -3.87 0.07
Stochastic Oscillator 54.98 76.18

Price Performance

Historical Comparison
IDCC
BLCO

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, Video, Artificial Intelligence, and related Technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically, it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, with the majority is from China.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: